STAGE IIIA INTRAOCULAR MELANOMA

Clinical trials for STAGE IIIA INTRAOCULAR MELANOMA explained in plain language.

Never miss a new study

Get alerted when new STAGE IIIA INTRAOCULAR MELANOMA trials appear

Sign up with your email to follow new studies for STAGE IIIA INTRAOCULAR MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Two-Pronged attack on deadly eye cancer

Disease control Ongoing

This study is testing whether taking one of two oral medications—sunitinib or valproic acid—for 6 to 12 months can help prevent a high-risk form of eye melanoma from spreading to other parts of the body after initial treatment. It involves 210 patients who have already had their …

Matched conditions: STAGE IIIA INTRAOCULAR MELANOMA

Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control

Last updated Apr 02, 2026 00:27 UTC

STAGE IIIA INTRAOCULAR MELANOMA

Get alerted when new STAGE IIIA INTRAOCULAR MELANOMA trials appear

Two-Pronged attack on deadly eye cancer